Work

Synergistic Multi-Target Therapy: berberine-Taxifolin Co-Administration Attenuates Murine Inflammatory Bowel Disease via NF-κB/NLRP3 Suppression and Intestinal Barrier Restoration

Cites: 16
Cited by:
Related to: 10